BPTH
BIO-PATH HOLDINGS, INC.Company Information
- Company Name
- BIO-PATH HOLDINGS, INC.
- CIK
- CIK0001133818
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BPTH: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BPTH
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2019-01-18
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 64,457
Institutional Sentiment
- As of
- 2025-03-31
- Institutional shares owned
- 31,127
- Shares outstanding
- 7,062,000
- Ownership
- 0.44%
Earnings Market Reaction
- Filing date
- 2026-05-20
- Price on filing date
- —
- 1-month reaction
- 14.80%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | - | - | 0 | 0 | 1 | 1 | 4 | 0 | 1 | 2 | - | ||||||
Assets | |||||||||||||||||
| Cash | 0 | - | - | - | - | - | 4 | 0 | 1 | 2 | 3 | ||||||
Assets Current | |||||||||||||||||
| Assets Current | 1 | 1 | 1 | 2 | 4 | 3 | 5 | 2 | 3 | 5 | 6 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Current | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | ||||||
| Property Plant And Equipment Gross | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Assets Noncurrent | |||||||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | - | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Property Plant And Equipment Net | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 1 | 1 | 2 | 4 | 3 | 5 | 2 | 3 | 5 | 7 | ||||||
| Accounts Payable Current | 5 | 5 | 3 | 2 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||
| Notes Payable Current | 1 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Accrued Liabilities Current | 3 | 3 | 4 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
Liabilities Current | |||||||||||||||||
| Derivative Liabilities | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 9 | 9 | 8 | 5 | 3 | 3 | 3 | 4 | 2 | 1 | 1 | ||||||
| Operating Lease Liability Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Warrants And Rights Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 9 | 9 | 8 | 5 | 4 | 4 | 4 | 4 | 3 | 2 | 1 | ||||||
| Preferred Stock Value | 0 | - | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Subscribed But Unissued | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | |||||||||||||||||
| Additional Paid In Capital | 118 | 118 | 118 | 118 | 118 | 114 | 114 | 108 | 108 | 107 | 106 | ||||||
| Stockholders Equity | -8 | -8 | -7 | -3 | 0 | -1 | 1 | -3 | 0 | 3 | 5 | ||||||
| Retained Earnings Accumulated Deficit | -126 | -126 | -125 | -120 | -118 | -115 | -113 | -111 | -108 | -104 | -101 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 2 | 4 | 3 | 5 | 2 | 3 | 5 | 7 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 9 | 9 | 8 | 8 | 6 | 4 | 2 | 1 | 1 | 1 | 0 | ||||||
| Shares Outstanding | 9 | 9 | 8 | 8 | 6 | 4 | 2 | 1 | 1 | 1 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIO-PATH HOLDINGS, INC. (BPTH) — SEC Financial Statements & Analysis
BIO-PATH HOLDINGS, INC. (BPTH) is a pharmaceutical preparations company, incorporated in WY. BIO-PATH HOLDINGS, INC. trades on OTC as: BPTH. BIO-PATH HOLDINGS, INC. (BPTH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-20. Based on that filing, BIO-PATH HOLDINGS, INC. carries a market cap of $560.54K, a P/E ratio of -0.06x, a P/B ratio of -0.07x, an enterprise value of $1.06M, and an EV/EBITDA multiple of -0.12x. On profitability, it posts a Return on Equity (ROE) of 208.71%, a Return on Assets (ROA) of -381.36%, and a Return on Invested Capital (ROIC) of -1235.00%. Per share, it reports EPS of $-0.93, diluted EPS of $-0.93, free cash flow per share of $-0.17, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -12.12% year-over-year and EPS growth of -77.41% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.02x, working capital of $-8.47M, a debt-to-equity ratio of -1.08x, a debt ratio of 13.53, an interest coverage ratio of -214.70x, free cash flow of $-1.63M (TTM), and net debt of $499.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $560.54K
- P/E TTM
- -0.06x
- EPS TTM
- $-0.93
- P/B TTM
- -0.07x
- ROE TTM
- 208.71%
- ROA TTM
- -381.36%
- Debt To Equity
- -1.08x
- Free Cash Flow TTM
- $-1.63M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIO-PATH HOLDINGS, INC. in?
BIO-PATH HOLDINGS, INC. (BPTH) operates in the Pharmaceutical Preparations industry.
What exchange does BPTH trade on?
BIO-PATH HOLDINGS, INC. (BPTH) trades on the OTC.
Where is BIO-PATH HOLDINGS, INC. incorporated?
BIO-PATH HOLDINGS, INC. is incorporated in WY.
When was BIO-PATH HOLDINGS, INC. (BPTH)'s most recent SEC filing?
BIO-PATH HOLDINGS, INC. (BPTH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-20.
What is BPTH's market cap?
BIO-PATH HOLDINGS, INC. (BPTH) has a market capitalization of $560.54K as of 2026-03-31.
What is BPTH's EPS (earnings per share)?
BIO-PATH HOLDINGS, INC. (BPTH)'s trailing twelve month EPS is $-0.93 as of 2026-03-31.
What is BPTH's ROE (return on equity)?
BIO-PATH HOLDINGS, INC. (BPTH)'s trailing twelve month Return on Equity (ROE) is 208.71% as of 2026-03-31.
What is BPTH's ROA (return on assets)?
BIO-PATH HOLDINGS, INC. (BPTH)'s trailing twelve month Return on Assets (ROA) is -381.36% as of 2026-03-31.
What is BPTH's ROIC (return on invested capital)?
BIO-PATH HOLDINGS, INC. (BPTH)'s trailing twelve month Return on Invested Capital (ROIC) is -1235.00% as of 2023-09-30.
What is BPTH's EV/EBITDA?
BIO-PATH HOLDINGS, INC. (BPTH)'s trailing twelve month EV/EBITDA is -0.12x as of 2026-03-31.